New Technology of Stroke Detection

Technology Desk Published: 12 December 2015, 06:19 AM | Updated: 10 November 2017, 11:49 AM
New Technology of Stroke Detection

A new system could diagnose a stroke in less than 10 minutes. For the 795,000 Americans each year who suffer a stroke, a rapid response diagnostic test may soon be at hand.

Scientists at Cornell University’s Baker Institute for Animal Health (BIAH) have created a system that can diagnose whether a stroke has taken place in less than 10 minutes using just a drop of blood—far quicker than the current means of testing, which relies on CT scans, full blood tests, and returns results in up to four hours.

With every minute counting for sufferers of the condition, which costs the economy $34 billion annually, this new device could prove life changing.

Modern medicine’s trend towards small size, simplicity, and speed is evident in this new diagnostic. “Three quarters of stroke patients suffer from ischemic stroke—a blockage of a blood vessel in the brain,” explains the study’s lead author, Roy Cohen.

“In those cases, time is of the essence, because there is a good drug available, but for a successful outcome it has to be given within three or four hours after the onset of symptoms. By the time someone identifies the symptoms, gets to the hospital, and sits in the emergency room you don’t have much time to obtain the full benefit of this drug.”

Enabling quicker diagnosis could reduce the number of people who suffer lasting damage from ischemic strokes, he says—an important consideration given that they are one of the leading causes of long-term disability in the U.S.

Strokes, which kill an American once every four minutes, can also cause problems such as excessive tiredness and vision problems in the long term for those who survive. BIAH’s technology will ultimately be able to detect biomarkers present in the blood when a stroke occurs by attaching enzymes to nanoparticles, which can convert those detected molecules into light.

Researchers focused on neuron-specific enolase (NSE), a biomarker found in more concentrated amounts in the blood of stroke victims, and measured the light they produced in order to diagnose whether this had taken place.